Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions emphasize the promising effects of semaglutide on reducing alcohol craving and consumption, and sometimes cigarette use, with words like 'significant,' 'novel,' and 'exciting,' which indicate both interest and perceived importance. The tone reflects curiosity about future trials and real-world applications, demonstrating deep engagement and recognition of potential high impact.
Most discussions highlight positive findings of the trial, suggesting strong support for the potential of semaglutide as a treatment option.
Posts show high interest, referencing clinical trials, specific outcomes, and implications for treatment, indicating engagement with the research's significance.
Discussions frequently mention specific results, such as reductions in alcohol cravings and consumption, and link the findings to broader implications, reflecting deep engagement.
The widespread sharing of detailed trial results, references to influential medical journals, and mentions of potential changes in clinical practice reveal a perception of high impact.
Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.4789 y 10.1056/NEJMra2306511 https://t.co/pSfARnkEu4
Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg https://t.co/XRnehyuJRx
Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/yFyD3tfukc https://t.co/afk2IARsYV
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/x2KCDS0zH2 https://t.co/hYGooWwghf
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/6dbD1K6UuC https://t.co/alzE5VdIec
Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol use d/o > Tested in a lab setting > Dose low (0.25-1 mg/wk), duration = 9 wk > Nicotine also improved https://t.co/yABfyoEE1K https://t.co/oNo41OJzTX
Preclinical studies suggest GLP-1 receptor agonists may lower alcohol consumption. A phase 2 trial with 48 adults showed semaglutide reduced alcohol cravings and intake during lab tasks over 9 weeks.
Preclinical studies suggest GLP-1 receptor agonists may reduce alcohol consumption. A phase 2 trial with weekly semaglutide in 48 adults over 9 weeks showed decreased cravings and alcohol intake in lab tasks…
A recent randomized clinical trial published in JAMA Psychiatry examined weekly semaglutide's impact on alcohol use disorder. The study found that semaglutide reduced alcohol cravings and consumption during lab tasks…
RT @berkerduman: Muhtemelen psikiyatrik hastalıklar arasında ilk onay alkol bağımlılığı tedavisinde olacak
RT @berkerduman: Muhtemelen psikiyatrik hastalıklar arasında ilk onay alkol bağımlılığı tedavisinde olacak
RT @berkerduman: Muhtemelen psikiyatrik hastalıklar arasında ilk onay alkol bağımlılığı tedavisinde olacak
Muhtemelen psikiyatrik hastalıklar arasında ilk onay alkol bağımlılığı tedavisinde olacak
Muhtemelen psikiyatrik hastalıklar arasında ilk onay alkol bağımlılığı tedavisinde olacak
@fuck_gubop Про алкоголизм есть вполне сильные исследования https://t.co/qD2qZJgfAv
@KyleKettlerMD @alphaenu https://t.co/341Vs8liCh They excluded less than 23 bmi here but yeah shall be interesting!
RT @ObesitySeen: "Over 9 weeks of treatment, semaglutide led to reductions in some but not all measures of weekly consumption, significantl…
RT @ObesitySeen: "Over 9 weeks of treatment, semaglutide led to reductions in some but not all measures of weekly consumption, significantl…
RT @ObesitySeen: "Over 9 weeks of treatment, semaglutide led to reductions in some but not all measures of weekly consumption, significantl…
"Over 9 weeks of treatment, semaglutide led to reductions in some but not all measures of weekly consumption, significantly reduced weekly alcohol craving relative to placebo, and led to greater relative reductions in cigarettes per day…" https://t.co/rcS4vPGsQW
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @DrPascalMeier: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/TtI2oPY94…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @DrPascalMeier: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/TtI2oPY94…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @DrPascalMeier: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/TtI2oPY94…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @DrPascalMeier: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/TtI2oPY94…
RT @DrPascalMeier: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/TtI2oPY94…
Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/TtI2oPY945 @JAMA_current https://t.co/Q8amiR8dka https://t.co/JOz3d4pbtk
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder https://t.co/eMAl3o9L28
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/2vX8YU8bun
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg ht…
Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/34SlX8MTwg https://t.co/XRnehyuJRx
Reported in @JAMAPsych Ozempic (semaglutide) decreases weekly alcohol consumption and craving. It also decreases cigarette use. https://t.co/UgQXo8Sxvu https://t.co/Sr6X7oX5wu
@Derma2ol FYI: https://t.co/8OIJoZgd8D
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/no0SAIWzYa https://t.co/FXkaSV5BUV
@MaineFrameworks @Aron_Adler About lifespan. https://t.co/4TRPpJzUBr
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder https://t.co/oW2PHDUF3y
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @Dra_TeraizaMesa: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with a…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/NoMY3buC3X https://t.co/pIcRVliCtX
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/NpQEjfAmvk https://t.co/fdjRgAknQx
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/03JlRzPEMG https://t.co/OBE9Gb90Ch
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/6dbD1K6UuC https://t.co/alzE5VdIec
@Row_Jimmy_Row https://t.co/RivvD69jMm
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/cR9R6UHwud https://t.co/fYPottOruB
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder https://t.co/H6T6vUREG7
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/Y1Iklbinoo https://t.co/NOkghXAfgW
RT @JAMAPsych: Can semaglutide help reduce alcohol craving and consumption in adults with alcohol use disorder? A randomized clinical tria…
RT @JAMAPsych: Can semaglutide help reduce alcohol craving and consumption in adults with alcohol use disorder? A randomized clinical tria…
RT @JAMAPsych: Can semaglutide help reduce alcohol craving and consumption in adults with alcohol use disorder? A randomized clinical tria…
RT @JAMAPsych: Can semaglutide help reduce alcohol craving and consumption in adults with alcohol use disorder? A randomized clinical tria…
Can semaglutide help reduce alcohol craving and consumption in adults with alcohol use disorder? A randomized clinical trial published in JAMA Psychiatry offers preliminary evidence: https://t.co/2MkrfGYlhO https://t.co/sTmj2kh7BW
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder https://t.co/qbGPOJskjB
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/jatA52boPk h…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/jatA52boPk h…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcoho…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/jatA52boPk h…
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/jatA52boPk h…
Most viewed this week from @JAMAPsych: Low-dose #semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/x2KCDS0zH2 https://t.co/hYGooWwghf
@horizontalescal @FrailSkeleton @cremieuxrecueil No, it actually seems to work via "attenuation of be- havioral and neurochemical measures of alcohol reward." Basically it reduces the cravings for it & reduces the buzz from drinking. Interesting study https://t.co/wDoIoJe3Vo
Once-Weekly #GLP-1 Drug Semaglutide (#Ozempic, #Wegovy) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder. And it reduced the number of cigarette smoked per day in the subgroup of smokers. @JAMAPsych https://t.co/pgcyvohbWU
Once-Weekly GLP-1 Drug Semaglutide (Ozempic, Wegovy) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder. And it reduced the number of cigarette smoked per day in the subgroup of smokers. @JAMAPsych https://t.co/pgcyvogE7m
Read the full article here: https://t.co/IPirkRE0u3
@cremieuxrecueil This is interesting but not surprising. Opioid, Alcohol, and Stimulant use disorders are showing positive results. https://t.co/iIYHrzX0AC
@KMan50000 @PaulSkallas Here's a paper on alcohol consumption: https://t.co/6R8Hl9BoJf
@ouranometrian2 https://t.co/Phv2J60OJS
Once-Weekly Semaglutide in Adults With Alcohol Use DisorderA Randomized Clinical Trial https://t.co/bbfL1uG93F
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/yFyD3tfukc https://t.co/afk2IARsYV
RT @JAMAPsych: Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol…
Most viewed this week from @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/SqAMvxKUCY https://t.co/RVRakeBaQR
RT @juancarlossaid: Semaglutide no sólo se ha vuelto un farmaco clave en manejo de obesidad y diabetes. Cada día hay más evidencia de su im…
RT @juancarlossaid: Semaglutide no sólo se ha vuelto un farmaco clave en manejo de obesidad y diabetes. Cada día hay más evidencia de su im…
RT @juancarlossaid: Semaglutide no sólo se ha vuelto un farmaco clave en manejo de obesidad y diabetes. Cada día hay más evidencia de su im…
RT @juancarlossaid: Semaglutide no sólo se ha vuelto un farmaco clave en manejo de obesidad y diabetes. Cada día hay más evidencia de su im…
RT @juancarlossaid: Semaglutide no sólo se ha vuelto un farmaco clave en manejo de obesidad y diabetes. Cada día hay más evidencia de su im…
Semaglutide no sólo se ha vuelto un farmaco clave en manejo de obesidad y diabetes. Cada día hay más evidencia de su impacto en consumo de alcohol e incluso en consumo de tabaco! https://t.co/tzTScj5rpS
Low-dose semaglutide can reduce craving and some drinking outcomes https://t.co/xDnyBrDJdC
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/jatA52boPk h…
https://t.co/L8XM3tEUvl https://t.co/3ryfW5WIdw
Semaglutida una vez a la semana en adultos con trastorno por uso del alcohol: ensayo clínico aleatorizado https://t.co/shpCNNogVK PMID 39937469
Semaglutide lowered alcohol intake, cravings, and smoking rates in adults with AUD.
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial https://t.co/51b7Rz6YoD
https://t.co/S6D8bUn2nz
【RCT-DB】オゼンピックで禁酒？ アルコール使用障害の48人に週1回低容量セマグルチドを9週間投与 プラセボに比べて、1日の飲酒量と大量摂取日が減少 飲酒したい欲求も低下 ついでに喫煙量も低下 軽度な副作用がみられた https://t.co/QWKk1xxsBW
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder:RCT; Low-dose semaglutide⬇️amount of alcohol consumed in posttreatment laboratory self-admin task, evidence of medium to large effect sizes for grams of alcohol consumed https://t.co/SsnaVR2MWC
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
Small N single centre study with dramatic results - so surely needs replication Semaglutide and alcohol craving In @jama.com Psychiatry jamanetwork.com/journals/jam... #MedSky #Glipination
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
RT @JAMAPsych: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. https://t.co/7KJm6hPJ8c
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/2vX8YU8bun
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/dz5Fwpn4nV
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
セマグルチドが、アルコール依存症の治療にも効果があるかも？RCTで、低用量でも飲酒量の減少とアルコール渇望の低下に効果があったとのこと。JAMA Psychiatry→ https://t.co/4gFFLJCuxs https://t.co/uYhoRyqHg0
Phase 2 trial: 9 weeks, 1x/week semaglutide vs placebo in adults with AUD. Results suggest GLP-1RAs reduce cravings and intake. #AUDResearch PMID:39937469, JAMA Psychiatry 2025, @JAMAPsych @PsychToday https://doi.org/10.1001/jamapsychiatry.2024.4789 #Medsky #Pharmsky #RNA
近年のGLP-1RAの勢いは異常。 https://t.co/3yq1LxyHyh
RT @EARL_med_tw: JAMA Psychiatry 2025 Feb.12
Phase 2 trial: 9 weeks, 1x/week semaglutide vs placebo in adults with AUD. Results suggest GLP-1RAs reduce cravings and intake. #AUDResearch PMID:39937469, JAMA Psychiatry 2025, @JAMAPsych @PsychToday https://t.co/DarHrRnnUA
Once-Weekly #Semaglutide in Adults With #Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and #Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/QfNxey3KdY
PD: la referencia al estudio: Hendershot CS, Bremmer MP, Paladino MB, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Published online February 12, 2025.
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
RT @muscle_penguin_: (452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望…
(452/347) #論文マラソン オゼンピックはアルコール摂取を減らすか？ RCT、プラセボ対照 低用量セマグルチドは消費アルコール量を減少させた。 飲酒日数には影響を及ぼさなかったが、飲酒日あたりの飲酒量と週あたりのアルコール渇望度を有意に減少させた。 https://t.co/BKFTZJ9uML
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
Optimistic findings: Hendershot CS, Bremmer MP, Paladino MB, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Published online February 12, 2025. doi:10.1001/jamapsychiatry.2024.4789
RT @RosaCasan: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medic…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry. Podemos aprovechar el tto con arGLP1 para que dejen alcohol y tabaco.@sociedadSEEN@diabeteSEEN https://t.co/1FahXcLkPz
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/UC4TE3DW0V
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder jamanetwork.com/journals/jam...
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @EARL_med_tw: JAMA Psychiatry 2025 Feb.12
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
Trend up+234: Hendershot CS, ..., Klein KR (JAMA Psychiatry) __Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial__ https://t.co/ATDeJ1Ucue
⭐️Featured Fridays⭐️ Please see below for an article that may be of interest to OED SIG members. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder A Randomized Clinical Trial https://t.co/MPiB00hD0F
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @docrobertsdiet: Interesting the links between central (in the brain) appetite regulation and addiction/reward. Once-Weekly Semaglutide…
Interesting the links between central (in the brain) appetite regulation and addiction/reward. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/akBhKoisTc
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder. A Randomized Clinical Trial https://t.co/3uAKOlebWg
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
"These findings provide initial prospective evidence that semaglutide can reduce craving and some drinking outcomes, justifying larger clinical trials to evaluate GLP-1RAs for alcohol use disorder." Interestingly, they also detected an effect on cigarette smoking: pubmed.ncbi.nlm.nih.gov/39937469/
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @EARL_med_tw: JAMA Psychiatry 2025 Feb.12
Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol use d/o > Tested in a lab setting > Dose low (0.25-1 mg/wk), duration = 9 wk > Nicotine also improved pubmed.ncbi.nlm.nih.gov/39937469
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @chrisaikenmd: Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol us…
Semaglutide (Ozempic) lowered drinking in 1st RCT of a GLP1 in addiciton. > Phase II trial, 48 patients with #alcohol use d/o > Tested in a lab setting > Dose low (0.25-1 mg/wk), duration = 9 wk > Nicotine also improved https://t.co/yABfyoEE1K https://t.co/oNo41OJzTX
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/xiaQmeIhj6
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
New evidence for treating AUD with semaglutide: phase 2 RCT including 48 participants showed a decrease in laboratory alcohol self-administration (and some self-measured outcomes). www.doi.org/10.1001/jamapsychiatry.2024.4789
JAMA Psychiatry 2025 Feb.12
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial | Substance Use and Addiction Medicine | JAMA Psychiatry | JAMA Network https://t.co/F6d416UrMS
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
“Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial” by Christian Hendershot et al. JAMA Psychiatry https://t.co/gQrU1TbmA4
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
"These findings provide initial prospective evidence that low-dose semaglutide can reduce craving and some drinking outcomes, justifying larger clinical trials to evaluate GLP-1RAs for alcohol use disorder." https://t.co/CBjlIIoZzS https://t.co/wKHXFTMCdj
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
RT @docramiro: Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.47…
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial Christian S. Hendershot, Michael P. Bremmer, Michael B. Paladino et al JAMA Psychiatry. February 12, 2025. doi:10.1001/jamapsychiatry.2024.4789 https://t.co/ypiQxhS4nv
Semaglutida para el trastorno por consumo de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.4789 y 10.1056/NEJMra2306511 https://t.co/pSfARnkEu4
Semaglutida para el trastorno por uso de alcohol - ensayo clínico fase 2 Referencias: doi:10.1001/jamapsychiatry.2024.4789 y 10.1056/NEJMra2306511 https://t.co/W3KQrXjbyf
The alcohol/Ozempic study also looked at cigarette use in the small number (13) of participants who also smoked. Caveat that it's just 13 patients, but here are the results, in JAMA Psychiatry today: doi:10.1001/jamapsychiatry.2024.4789
Original open access investigation: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder A Randomized Clinical Trial
expert reaction to study looking at once-weekly semaglutide in adults with alcohol use disorder
JP
M
G
DÖ
BD
MD
DN
JA
JL
MT
O
PP
F
DD
TR
LE
DP
MP
BM
VS
L
L
DB
HH
G
DP
RD
AT
KD
MM
AR
DM
NP
H
SH
EM
JE
FB
A
김K
AG
ER
W
DE
HM
CH
DG
JC
KM
TD
DV
W
GK
CM
MS
FM
C
R
JT
MA
PG
NR
CD
PM
JS
YL
DM
JR
Z
AB
TD
C
MP
PO
SL
V
FX
JM
PO
RP
NV
C
DH